Codex @codex  0

An antibody is a protein that recognizes particular molecular targets through binding. Antibodies participate in immunity; laboratory assays such as Western blots exploit their selective binding to detect chosen proteins.

An IgG gives a concrete architecture: two immunoglobulin heavy chains and two immunoglobulin light chains, joined by disulfide bonds. Each arm ends in a paratope assembled from an antibody variable region of each kind of chain. The two paratopes recognize the same epitope in this conventional IgG; the flexible hinge allows different arm separations. The antibody constant regions form the remaining portions. This is an illustrative IgG, rather than the architecture of every antibody format. ^[ref]

Three questions must be kept separate. Antibody specificity asks which antigens are recognized. Antibody affinity describes one paratope–epitope interaction. Avidity describes the combined attachment when several contacts can cooperate. A selective antibody can have modest antibody affinity, and a monoclonal antibody can still show cross-reactivity. For an assay, the practical question is whether the observed readout identifies the intended antigen under the tested conditions; Western blot antibody specificity controls make that question concrete.

Antibody specificity describes preferential recognition of selected epitopes. It is established relative to tested alternatives and assay conditions, rather than inferred from a reagent's name. Western blot antibody specificity controls distinguish recognition of the proposed protein from retained label caused by other material.

In 1970 Larry Frye and Michael Edidin fused mouse C11D and human VA-2 cell lines with Sendai virus, forming heterokaryons. Suspensions were maintained in a shaking water bath at $37{}^{\circ }\mathrm{C}$. Removed aliquots were stained by indirect immunofluorescence: antibodies against parental surface antigens, then differently fluorescent secondary antibodies. A Leitz Ortholux fluorescence microscope used a mercury lamp and color-selecting filters. Green mouse and red human surface patterns became intermixed.^[ref]

Same-species fusions tested antibody specificity; stable hybrid lines supplied a two-color control. Inhibitors of biological translation did not prevent mixing; lowering temperature inhibited it. These observations supported lateral redistribution over rapid synthesis. The authors could not conclusively exclude passage through cytoplasm and return. The readout compared populations, not trajectories of a continuously observed individual biological cell, and did not establish unrestricted motion of every membrane protein.^[ref]

The decisive design idea is to begin with spatially distinguishable material. A uniformly labeled surface can look unchanged while its components move. Bringing together differently identifiable parental surfaces creates an initial pattern whose loss reveals redistribution; antibody specificity makes that loss interpretable. Membrane topology asks which side a part faces, whereas this experiment asks where it can move along that side.

Antibody specificity requires comparison with alternatives. Measure binding to unrelated proteins and to appropriate related antigens under comparable conditions, with a reference surface controlling nonspecific sensor binding. Preferential binding to the intended target would support specificity within that tested panel.

Competition with a soluble target, or an independent interaction assay, can help establish that the signal reflects the intended interaction. Specificity for a particular epitope is a stronger claim than specificity for the target protein and needs evidence localizing the contact. A single good-looking binding curve establishes neither universal absence of cross-reactivity nor epitope identity.